Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms

Ítems similars

• Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia
  per: Anand A. Patel, et al.
  Publicat: (2024-10-01)
• Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
  per: Gabriela S. Hobbs, et al.
  Publicat: (2018-01-01)
• Interferons in the treatment of myeloproliferative neoplasms
  per: Pankit Vachhani, et al.
  Publicat: (2024-02-01)
• P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS
  per: U. Pakulska, et al.
  Publicat: (2022-06-01)
• Atypical Presentation of Erythroid/Megakaryocytic Leukemic Transformation of a Myeloproliferative Neoplasm Associated with Mutation and Loss of TP53
  per: Brian J. Chernak, et al.
  Publicat: (2020-08-01)